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Background/introduction
The minimally invasive nature of FUS makes it an excel-
lent candidate technology for epilepsy surgery. The limita-
tion of currently available FUS systems is that the lesion
must be deep in the brain to avoid bone heating. Thus, it
is best suited for “subcortical” epilepsies, i.e. epilepsy
resulting from lesions below the cortex. It is also desirable
that the lesion be relatively small volume to avoid long
treatment times and not be in eloquent cortex. Previous
reports of seizure freedom after laser ablation of hypotha-
lamic hamartomas and radiofrequency ablation of single
subcortical nodules have been reported.
Thus, we designed the Focused Ultrasound Subcortical
Epilepsy (FUSE) study with these principles in mind.
Methods
The FUSE study is an open label safety and feasibility
pilot study. It will enroll 15 subjects with subcortical
lesions as the cause of medically refractory epilepsy,
including hypothalamic hamartomas, periventricular
nodular heterotopia, focal “cortical” dysplasia that is suf-
ficiently far from the skull, and hamartomas of tuberous
sclerosis. The main outcome is safety and feasibility of
ablating the lesion but secondary outcome includes sei-
zure reduction. Subjects will undergo a single MR guided
FUS treatment session. Subjects may be sedated since
they are likely to be in the MRI for 2-4 hours. A targeting
model will be created before the procedure. Low tem-
perature heating will first insure proper localization of
energy at the lesion, and then a high temperature abla-
tion will be performed. If this study is successful, then it
could change the standard treatment of hypothalamic
hamartoma which now currently is primarily treated by
laser ablation or open surgery. If the study is successful
in treating periventricular nodules then it could be
transformative for these patients because there is cur-
rently no common method of surgical treatment.
FUS has a high potential to provide effective ablation of
subcortical lesions causing epilepsy. Future developments
will likely allow a larger treatment envelope and expand its
use to other epilepsies. If it is a low risk procedure then it
could shift the risk-benefit ratio towards empiric treatment
of lesions and help avoid intracranial monitoring and its
attendant risks.
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